InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Chadha Deepak, Directeur de la Recherche et du Développement. Officer active across 2 companies, notably Brickell Biotech, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €4k. The latest transaction was filed on 18 May 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€1,8092,700 shares@ €0.6701100.0% of flow
Common Stock
SEC:0001062993-21-004866·
Ideal exit: 12 Feb 2022 (T+270)
€1,8092,700 shares@ €0.670150.0% of flow
Common Stock
SEC:0001062993-21-004866:0·
Ideal exit: 12 Feb 2022 (T+270)
2 of 2 declarations
About Chadha Deepak
Deepak Chadha is the Chief Research & Development Officer at Brickell Biotech, Inc. He is responsible for innovation and the development of new products within the company.
